About 60mg Daclahep Daclatasvir Tablets
| Strength |
60 mg |
| Manufactured By |
Hetero Healthcare Ltd |
| Brand |
Daclahep |
| Packaging Type |
Bottle |
| Pack Size |
28 Tablets |
| Composition |
Daclatasvir |
| Treatment |
Treatment of Chronic Hepatitis C Virus Infection |
Daclahep 60mg Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.
Daclahep 60mg Tablet should be taken in the dose and duration as advised by your doctor. It should be taken with or without food, preferably at a fixed time. Do not skip any doses and finish the full course of treatment even if you feel better If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
What is Daclahep Daclatasvir 60mg used for?Daclahep Daclatasvir 60mg is an antiviral medication primarily indicated for the treatment of chronic Hepatitis C virus (HCV) infection in adults. Its active ingredient, Daclatasvir Dihydrochloride, works to inhibit the replication of the hepatitis C virus, facilitating effective viral clearance when used as directed by a physician.
How should you take Daclahep Daclatasvir?Daclahep tablets must be taken orally, once daily, with or without food, as prescribed by your healthcare provider. It is important to follow your physician's instructions and to complete the entire course to achieve the best therapeutic outcome and reduce the risk of viral resistance.
What are the safety and storage guidelines?This medication is suited for adult patients and is not recommended for pediatric use. Store Daclahep in its original blister pack, below 30C, in a cool, dry place away from direct sunlight. Always keep it out of reach of children and do not use it past its expiry date.
FAQ's of 60mg Daclahep Daclatasvir Tablets:
Q: How does Daclahep Daclatasvir 60mg benefit patients with Hepatitis C?
A: Daclahep Daclatasvir 60mg works by inhibiting the replication of the Hepatitis C virus within the body. When taken as directed in combination with other antiviral agents, it increases the likelihood of clearing the infection and improving liver health.
Q: What is the recommended process for starting Daclahep therapy?
A: Daclahep therapy should be initiated only after a confirmed diagnosis of chronic Hepatitis C and evaluation by a licensed healthcare provider. A valid prescription is required, and your physician will determine the appropriate combination therapy and duration based on your health profile.
Q: When should Daclahep be taken during the day?
A: Daclahep can be taken at any time of the day, but it is best to take it at the same time each day to maintain consistent levels in the body. You may take the tablet with or without food, according to your physician's instructions.
Q: What interactions should be considered with Daclahep Daclatasvir?
A: Daclahep may interact with strong CYP3A inducers such as rifampicin or carbamazepine, potentially reducing its effectiveness. Inform your doctor about any medications, herbal products, or supplements you are taking before starting this treatment.
Q: What are the common side effects of Daclahep Daclatasvir tablets?
A: Common side effects include headache, fatigue, and nausea. If you experience severe or unusual symptoms, contact your healthcare provider promptly for further advice.
Q: Where can you find the retail price and packaging information for Daclahep?
A: The Maximum Retail Price (MRP) of Daclahep is indicated on the packaging, which contains a barcode for verification. Each box holds 28 film-coated tablets, packaged securely in blister packs with all labeling required by Indian regulations.